QA: Concert Pharmaceuticals INC in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001367920_2017_Concert_Pharmaceuticals_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001367920, Concert Pharmaceuticals INC

  xvar xval
0 AssetsCurrent 97,729,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,199,000
3 remainder_Assets 467,000
4 LiabilitiesCurrent 5,570,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 9,231,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 14,358,000
9 ResearchAndDevelopmentExpense 36,983,000
10 remainder_Expenses 0
11 remainder_Revenues 174,000
12 remainder_NetIncome 447,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 100,395,000
1 Liabilities 14,801,000
2 Expenses 51,341,000
3 Revenues 174,000
4 StockholdersEquity 85,594,000
5 NetIncome -50,720,000
6 ComprehensiveNetIncome -50,720,000
7 BaseVar 83,579,000
8 EconomicCapitalRatiobeforeLimitedLiability 2.36
9 EconomicCapitalRatio 3.26

Edgar->Model Mapping

Feature Distribution

Change over Time